Aims of the meeting were: - Provide an overview of the activities, role, rationale and impact of patient and advocacy groups in Europe and the US in terms of prevention and control of viral Hepatitis; - Give examples of experiences of international and national patient and advocacy groups in Europe and the US; - Identify challenges and thresholds experienced by liver patient groups regarding their